Zydus Mounts Challenge To Novartis With Generic Nelarabine Injection

US Rival To Arranon Has Been Granted 180 Days Of CGT Exclusivity

 
• By Chloe Kent
  
US Flag Graph
Zydus is building up its US injectables business • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin